Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Videos | HRS

VIDEO: Top New EP Technologies at Heart Rhythm Society 2020

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

May 22, 2020

News | EP Lab

FDA Approves Medtronic Cobalt and Crome ICD Portfolio

May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome ...

May 12, 2020

$The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020$

News | Implantable Cardioverter Defibrillator (ICD)

UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

May 08, 2020

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD)

Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

May 08, 2020

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | Valentina Kutyifa M.D., Ph.D.

BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

March 09, 2020

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Feature | EP Lab | Hrishikesh Kadam

The Future of Cardiac Rhythm Management Device Technology

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

November 11, 2019

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

News

Cleveland Clinic Unveils Top 10 Medical Innovations for 2020

November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...

November 06, 2019

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extrava ...

October 11, 2019

News | Implantable Cardioverter Defibrillator (ICD)

Early ICD Use Prolongs Survival After Coronary Stenting

September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention ...

September 18, 2019

News | Leads Implantable Devices

Abbott Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires

August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical ...

August 05, 2019

News | EP Lab

Cardiac Device Complications Vary Widely Among Hospitals

July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary ...

July 31, 2019

The Zoll Lifevest Wearable External Defibrillator Offers a Bridge Therapy and buys time for physicians to determine if an implantable defibrillator is needed.

News | Sudden Cardiac Arrest

Wearable Defibrillator Offers a Bridge Therapy

For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable cardioverter ...

July 02, 2019

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell, Editor

New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators

This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...

May 24, 2019

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

News | EP Lab

Implantable EP Device Infection Risk Score Unveiled at HRS 2019

May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The ...

May 15, 2019

News | EP Lab

Studies Find Race and Gender Disparities in Implantable Heart Devices

May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, including ...

May 15, 2019